Envisagenics
Latest round
- Series B
Last raised
- Jun 2024
Total raised
- $27M
Investors
- 11
About Envisagenics
Founded in 2014 and based in New York, US, Envisagenics, Inc. operates as a developer of predictive analytics platforms that allow scientists to translate basic discoveries into therapies. Maria Luisa Pineda (CEO) and Martin Akerman (CTO) are the co-founders of the company. In June 2024, Envisagenics, Inc.99 million post-money. The company’s pipeline includes the SpliceCore® platform, which specializes in the identification and validation of drug targets by leveraging RNA sequencing data. SpliceCore® enhances the discovery of novel splicing-derived targets and elucidates the mechanisms of antisense drug regulation. In addition, SpliceIOTM, a branch of SpliceCore®, focuses on identifying tumor-specific neoepitopes for immunotherapy.
Who invested in Envisagenics
11 investors across 3 rounds
See all investors in Envisagenics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Envisagenics
Who invested in Envisagenics?
Envisagenics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Envisagenics raised?
Envisagenics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Envisagenics last raise money?
Envisagenics's most recent round on record is a Series B, in Jun 2024.
What does Envisagenics do?
Founded in 2014 and based in New York, US, Envisagenics, Inc.
Where is Envisagenics headquartered?
Envisagenics is headquartered in New York, US.
Which VCs invest in companies like Envisagenics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Envisagenics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Envisagenics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.